Bad Blood: Anemia Management Updates in the Setting of Chronic Kidney Disease
Mayo Clinic Pharmacy Grand RoundsShow Notes
Mark Layden, PharmD, MBA shares the place in therapy for hypoxia-inducible factor prolyl hydroxylase inhibitors and other general approaches to anemia management in chronic kidney disease. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
More from Mayo Clinic Pharmacy Grand Rounds
Damon Alvarez, PharmD, MBA provides insights on statin use in people living with HIV.
Kennedy Concannon, PharmD discusses the use of thiamine in septic shock.
Katie Bye, PharmD shares insights on buprenorphine induction strategies for opioid use disorders.
Brandy Hernandez, PharmD shares nuances on the use of uridine triacetate and glucarpidase in chemotherapy toxicity management
Taylor Gullickson, PharmD educates on the use of beta-blockers in portal hypertension